Cipla Limited (LUX:CIPLA)

Luxembourg flag Luxembourg · Delayed Price · Currency is EUR · Price in USD
17.80
-0.30 (-1.66%)
At close: Jul 30, 2025
-1.66%
Market Cap12.51B
Revenue (ttm)2.73B
Net Income (ttm)535.38M
Shares Outn/a
EPS (ttm)0.66
PE Ratio23.36
Forward PE24.88
Dividend0.12 (0.71%)
Ex-Dividend DateJun 26, 2025
Volumen/a
Average Volumen/a
Openn/a
Previous Close18.10
Day's Rangen/a
52-Week Range15.97 - 19.83
Betan/a
RSI65.82
Earnings DateJul 28, 2025

About Cipla

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer’s disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obe... [Read more]

Industry Pharmaceutical Preparations
Founded 1935
Employees 30,313
Stock Exchange Luxembourg Stock Exchange
Ticker Symbol CIPLA
Full Company Profile

Financial Performance

In 2024, Cipla's revenue was 272.67 billion, an increase of 6.78% compared to the previous year's 255.37 billion. Earnings were 52.73 billion, an increase of 27.93%.

Financial numbers in INR Financial Statements

News

There is no news available yet.